SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ohrfelt Annika)
 

Search: WFRF:(Ohrfelt Annika) > Evaluation of the C...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003429naa a2200433 4500
001oai:lup.lub.lu.se:c496ca1d-0235-41c2-a64c-f9cafb310b55
003SwePub
008160401s2013 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/42725982 URI
024a https://doi.org/10.1159/0003534422 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Nutu, Magdalena4 aut
2451 0a Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
264 c 2013-07-09
264 1b S. Karger AG,c 2013
520 a Background: The well-established core biomarkers used to identify Alzheimer's disease (AD) overlap with other dementia disorders such as dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). This study aimed to evaluate whether the cerebrospinal fluid (CSF) amyloid-beta (A beta)(1-42)/A beta(1-40) ratio, measured by a novel method, could improve the differential diagnosis of AD, DLB and PDD. Method: CSF levels of A beta(1-40) and A beta(1-42) in patients with PDD, DLB, AD, Parkinson's disease and controls were analyzed using an amplified luminescent proximity homogenous immunoassay along with conventional immunoassays. Results: The CSF A beta(1-42)/A beta(1-40) ratio increased discrimination of AD from PDD and DLB compared with either of the two A beta biomarkers individually. Conclusion: The use of the A beta(1-42)/A beta(1-40) ratio could improve the differentiation of AD from PDD and DLB. (C) 2013 S. Karger AG, Basel
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
653 a Amyloid-beta
653 a Alzheimer's disease
653 a Parkinson's disease
653 a Immunoassays
653 a Amplified luminescent proximity homogenous immunoassay
700a Zetterberg, Henrik4 aut
700a Londos, Elisabetu Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)pski-elo
700a Minthon, Lennartu Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)psyk-lmi
700a Nägga, Katarinau Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)med-kng
700a Blennow, Kaj4 aut
700a Hansson, Oskaru Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups4 aut0 (Swepub:lu)mphy-ohn
700a Ohrfelt, Annika4 aut
710a Klinisk minnesforskningb Forskargrupper vid Lunds universitet4 org
773t Dementia and Geriatric Cognitive Disordersd : S. Karger AGg 36:1-2, s. 99-110q 36:1-2<99-110x 1420-8008x 1421-9824
856u http://dx.doi.org/10.1159/000353442y FULLTEXT
8564 8u https://lup.lub.lu.se/record/4272598
8564 8u https://doi.org/10.1159/000353442

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view